2004
Citations
0
Influential Citations
0
Citations
Quality indicators
Journal
Artificial Intelligence Review
Abstract
Aims of Study: Orally administered desmopressin has been available for the treatment of nocturnal enuresis and diabetes insipidus for more than 10 years. The data presented are collated from several studies taken from an extensive research program to describe the pharmacokinetics of oral desmopressin with respect to age, gender, time of administration (day or night), metabolism and food interaction in healthy and nocturic individuals. Methods: Either 200 μg or 400 μg of desmopressin acetate (dDAVP) were administered orally to healthy or nocturic males or females with ages in the range of 18–85 years.